Clinical Feature of Men Who Benefit from Dose Escalation of Naftopidil for Lower Urinary Tract Symptoms: A Prospective Study
Figure 1
Alteration of the total IPSS (a), storage (b), voiding (c), postmicturition (domain for feeling of incomplete emptying) (d), and QOL (e) scores in men with dose escalation from 50 mg/day to 70 mg/day of naftopidil (75 mg group) and those maintained with its 50 mg/day (50 mg group).
